Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP964121.RAnjj7tixddtrmQt1zfKlh2aWJLyvbUKbLoPHY3RjsRm0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP964121.RAnjj7tixddtrmQt1zfKlh2aWJLyvbUKbLoPHY3RjsRm0130_assertion type Assertion NP964121.RAnjj7tixddtrmQt1zfKlh2aWJLyvbUKbLoPHY3RjsRm0130_head.
- NP964121.RAnjj7tixddtrmQt1zfKlh2aWJLyvbUKbLoPHY3RjsRm0130_assertion description "[With the recognition that PCFT is abundantly expressed in human tumors and is active at pHs characterizing the tumor microenvironment, attention turned to exploiting PCFT for delivering novel cytotoxic antifolates for solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP964121.RAnjj7tixddtrmQt1zfKlh2aWJLyvbUKbLoPHY3RjsRm0130_provenance.
- NP964121.RAnjj7tixddtrmQt1zfKlh2aWJLyvbUKbLoPHY3RjsRm0130_assertion evidence source_evidence_literature NP964121.RAnjj7tixddtrmQt1zfKlh2aWJLyvbUKbLoPHY3RjsRm0130_provenance.
- NP964121.RAnjj7tixddtrmQt1zfKlh2aWJLyvbUKbLoPHY3RjsRm0130_assertion SIO_000772 22954694 NP964121.RAnjj7tixddtrmQt1zfKlh2aWJLyvbUKbLoPHY3RjsRm0130_provenance.
- NP964121.RAnjj7tixddtrmQt1zfKlh2aWJLyvbUKbLoPHY3RjsRm0130_assertion wasDerivedFrom befree-20150227 NP964121.RAnjj7tixddtrmQt1zfKlh2aWJLyvbUKbLoPHY3RjsRm0130_provenance.
- NP964121.RAnjj7tixddtrmQt1zfKlh2aWJLyvbUKbLoPHY3RjsRm0130_assertion wasGeneratedBy ECO_0000203 NP964121.RAnjj7tixddtrmQt1zfKlh2aWJLyvbUKbLoPHY3RjsRm0130_provenance.